Holly May
Corporate Officer/Principal chez BIOLINERX LTD.
Fortune : - $ au 31/03/2024
Profil
Holly W.
May is currently the President-BioLineRx USA at BioLineRx Ltd.
She previously worked as the Vice President-Sales & Marketing at Swedish Orphan Biovitrum AB from 2018 to 2019.
Before that, she held positions as the Chief Commercial Officer at Avrobio, Inc., Vice President & Head-Commercial at Sobi, Inc., Vice President at Genzyme Israel Ltd., and Head-Marketing Operations at Sanofi-Aventis Israël Ltd.
Ms. May holds an MBA from the University of Akron and an undergraduate degree from the University of Miami.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOLINERX LTD.
-.--% | 15/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Holly May
| Sociétés | Poste | Début |
|---|---|---|
| BIOLINERX LTD. | Corporate Officer/Principal | 16/06/2022 |
Anciens postes connus de Holly May
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Sales & Marketing | 01/08/2019 |
| Sanofi-Aventis Israël Ltd. | Sales & Marketing | - |
| Genzyme Israel Ltd. | Corporate Officer/Principal | - |
| Sobi, Inc. | Corporate Officer/Principal | - |
| AVROBIO, INC. | Corporate Officer/Principal | - |
Formation de Holly May
| University of Akron | Masters Business Admin |
| University of Miami | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOLINERX LTD. | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Sanofi-Aventis Israël Ltd. | |
| Sobi, Inc. | |
| Genzyme Israel Ltd. |
